FBIOP — Fortress Biotech, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2017-11-14.
Performance
Technicals
Others in Healthcare
Measured signals that fired on FBIOP
| date | signal | measured base rate |
|---|---|---|
| 2026-07-14 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-22 | Jin David Chief Financial Officer | Grant or award | 400.0K | 0.00 | 0 |
| 2026-04-01 | Jin David Chief Financial Officer | Grant or award | 3.0K | 2.18 | 6.5K |
| 2026-03-18 | ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN | Grant or award | 475.4K | 0.00 | 0 |
| 2026-03-18 | WEISS MICHAEL S Executive Vice Chairman | Grant or award | 475.4K | 0.00 | 0 |
| 2026-01-01 | Hoenlein Malcolm Director | Grant or award | 27.3K | 0.00 | 0 |
| 2026-01-01 | LOBELL J JAY Director | Grant or award | 27.3K | 0.00 | 0 |
| 2026-01-01 | Klein Dov Director | Grant or award | 27.3K | 0.00 | 0 |
| 2026-01-01 | Harvey Jimmie Director | Grant or award | 27.3K | 0.00 | 0 |
| 2026-01-01 | Lorenz Kevin Director | Grant or award | 27.3K | 0.00 | 0 |
| 2025-10-01 | Jin David Chief Financial Officer | Grant or award | 2.7K | 1.31 | 3.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about FBIOP
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →